WO2025017530 - SOLID STATE FORMS OF BUNTANETAP AND PROCESS FOR PREPARATION THEREOF
National phase entry is expected:
Publication Number
WO/2025/017530
Publication Date
23.01.2025
International Application No.
PCT/IB2024/057035
International Filing Date
19.07.2024
Title **
[English]
SOLID STATE FORMS OF BUNTANETAP AND PROCESS FOR PREPARATION THEREOF
[French]
FORMES SOLIDES DE BUNTANETAP ET LEUR PROCÉDÉ DE PRÉPARATION
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SOMASUNDARAM, Meenakshi Sundaram
GANDE, Laxman
Priority Data
202311048390
19.07.2023
IN
202311051017
28.07.2023
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3192 | |
| EPO | Filing, Examination, Granting | 24690 | |
| Japan | Filing, Examination, Granting | 3110 | |
| South Korea | Filing, Examination, Granting | 4042 | |
| USA | Filing, Examination, Granting | 11740 |
Total:
46,774
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure encompasses solid state forms of Buntanetap, in embodiments crystalline polymorphs of Buntanetap or salts of Buntanetap, particularly Buntanetap tartrate, processes for preparation thereof, and pharmaceutical compositions thereof.[French]
La présente divulgation concerne des formes solides de Buntanetap, selon certain modes de réalisation, des polymorphes cristallins de Buntanetap ou des sels de Buntanetap, en particulier du tartrate de Buntanetap, des procédés de préparation de ceux-ci, et des compositions pharmaceutiques de ceux-ci.